Li Auto (NASDAQ:LI) Stock, Quote.Headers.trade-ideas

Li Auto

Li Auto is a leading Chinese NEV manufacturer that designs, develops, manufactures, and sells premium smart NEVs. The company started volume production of its first model Li One in November 2019. The model is a six-seater, large, premium plug-in electric SUV equipped with a range extension system and advanced smart vehicle solutions. It sold over 376,000 NEVs in 2023, accounting for about 4% of China's passenger new energy vehicle market. Beyond Li One, the company expands its product line, including both BEVs and PHEVs, to target a broader consumer base.

Li Auto Inc

Trade And Tariff Policies

Equities

News

Markets

General

BABA

BIDU

XPEV

The WTO chief issued a warning on Thursday about the potentially disastrous impact of trade wars on global economic growth.

WTO Chief Says &#39;Everyone Will Pay&#39; If &#39;Tit-For-Tat&#39; Trade War Breaks Out Amid Trump&#39;s Tariff Threat, Leading To Double-Digit Global GDP Losses

Tongyi,Qianwen,Logo,Seen,On,Smartphone,Screen.,Tongyi,Qianwen,Ai

Emerging Markets

Tech

Media

Citigourp Global Markets 2% Protected Notes Linked To The Djia

Alibaba Cloud launched expanded suite of LLMs and AI development tools, collaborating to develop AI and cloud-computing solutions for global businesses.

Alibaba Cloud Unveils New AI Tools and Language Models to Empower Global Developers

Criticism Of China

Asia

Government

Emerging Market ETFs

Politics

ETFs

KWEB

President Donald Trump told reporters on Tuesday that he is considering a 10% tariff on goods from China that could take effect as soon as Feb.1. 

Trump &#39;Looking At&#39; 10% Tariff On China Starting Feb. 1

Li Auto Inc. - American Depositary Shares

Stone Ridge 2048 Inflation-Protected Longevity Income ETF

Stone Ridge 2049 Inflation-Protected Longevity Income ETF

Stone Ridge 2050 Inflation-Protected Longevity Income ETF

Stone Ridge 2051 Inflation-Protected Longevity Income ETF

Stone Ridge 2052 Inflation-Protected Longevity Income ETF

Stone Ridge 2053 Inflation-Protected Longevity Income ETF

Stone Ridge 2054 Inflation-Protected Longevity Income ETF

Stone Ridge 2055 Inflation-Protected Longevity Income ETF

LianBio ADS (Sponsored)

LianBio

Stone Ridge 2056 Inflation-Protected Longevity Income ETF

Stone Ridge 2057 Inflation-Protected Longevity Income ETF

Stone Ridge 2058 Inflation-Protected Longevity Income ETF

Stone Ridge 2059 Inflation-Protected Longevity Income ETF

Stone Ridge 2060 Inflation-Protected Longevity Income ETF

Stone Ridge 2061 Inflation-Protected Longevity Income ETF

Stone Ridge 2062 Inflation-Protected Longevity Income ETF

Stone Ridge 2063 Inflation-Protected Longevity Income ETF

Stone Ridge Trust Stone Ridge 2064 Inflation-Protected Longevity Income ETF

Stone Ridge Trust Stone Ridge 2065 Inflation-Protected Longevity Income ETF

LIBERTY PLUGINS INC by Liberty PlugIns, Inc.

Liberty Resources Acquisition Corp Ordinary Shares - Class A

Liberty Resources Acquisition Corp

Liberty Resources Acquisition Corp Units (1 Ord Class A & 1 War)

Liberty Resources Acquisition Corp Warrants - (31/10/2028)

Livechain Inc

Lichen China Limited - Class A Ordinary Shares

Lichen China Ltd

LICT Corp

Li-Cycle Holdings Corp

Limco Del Mar

AEye Inc

Chicago Atlantic BDC, Inc. - Common Stock

Chicago Atlantic BDC Inc

Life360 Inc

Life Corp

LFTD Partners Inc

LIFE TECHNOLOGIES CORP COM

Life Crypto

Li-FT Power Ltd

LIF3 - United States Dollar

LIFENET INSURANCE CO. by Lifenet Insurance Co.

Lifenet Insurance Co

LIFE STEM GENETICS INC by Life Stem Genetics Inc.

Life Stem Genetics Inc

LABRADOR IRON ORE RLTY CP by Labrador Iron Ore Royalty Corp.

Labrador Iron Ore Royalty Corp

LIG Assets Inc

Lightning

Lennox International Inc

LikeCoin

Liberty Latin America Ltd. - Class A Common Stock

Liberty Latin America Ltd

LIBERTY LATIN AMERICA B by Liberty Latin America Ltd.

Liberty Latin America Ltd. - Class C Common Stock

ARGENTINA LITH & ENERGY by Argentina Lithium & Energy Corp

Argentina Lithium & Energy Corp

LILIUM N V SHS CL A

Lilium NV

LILIUM N V WT EXP

Linamar Corp

iMe Lab

Li-Metal Corp

Themes ETF Trust Themes Lithium & Battery Metal Miners ETF

LIMITLESS X HOLDINGS INC by Limitless X Holdings Inc.

Limitless X Holdings Inc

Linde PLC

Linear Finance

Lincoln Educational Services Corporation - Common Stock

Lincoln Educational Services Corp

Lindblad Expeditions Holdings Inc. - Common Stock

Lindblad Expeditions Holdings Inc

Lineage Inc

LINDIAN RESOURCES LTD by LINDIAN RESOURCES LTD.

Lindian Resources Ltd

Interlink Electronics, Inc. - Common Stock

Interlink Electronics Inc

Chainlink - United States Dollar

LINKDOWN - United States Dollar

Chainlink - TrueUSD

LINKUP - United States Dollar

LIONTOWN RESOURCES LTD by Liontown Resources Ltd.

Liontown Resources Ltd

LIFE INS CO ALA by Life Insurance Co. Of Alabama

Life Insurance Co

LIFE INS CO ALA A by Life Insurance Co. Of Alabama

LINIU TECHNOLOGY GRP ORD by LiNiu Technology Group

LiNiu Technology Group

Lion Energy Ltd

Lionsgate Studios Corp

Lion Corp

Lipella Pharmaceuticals Inc. - Common Stock

Lipella Pharmaceuticals Inc

LIQUID HOLDINGS GROUP INC by Liquid Holdings Group, Inc.

Liquid Holdings Group Inc

LIQUID META CAP HLDGS LTD by Liquid Meta Capital Holdings Ltd.

LiqTech International, Inc. - Common Stock

LiqTech International Inc

LITHIUM SOUTH DEV CORP by Lithium South Dev Corp.

Lithium South Development Corp

Li-S Energy Ltd

Global X Lithium & Battery Tech ETF

Litentry - United States Dollar

LightInTheBox Holding Co., Ltd. American Depositary Shares, each representing twelve ordinary shares

LightInTheBox Holding Co Ltd

Lumentum Holdings Inc

BioELife Corp

Lithium

Snow Lake Resources Ltd

Frontier Lithium Inc

Earnings

Health Care

Dr Reddy's Laboratories Q3 2025 GAAP EPS $0.20 Versus $0.19 YoY, Sales $977.00M Compared To $843M YoY

Baird analyst Peter Arment maintains Textron (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TXT#NYSE">TXT</a>) with a Outperform and lowers the price target from $100 to $92.

Price Target

Analyst Ratings

Baird Maintains Outperform on Textron, Lowers Price Target to $92

Keybanc analyst Ashley Owens upgrades Boot Barn Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOOT#NYSE">BOOT</a>) from Sector Weight to Overweight and announces $190 price target.

Upgrades

BOOT

Keybanc Upgrades Boot Barn Holdings to Overweight, Announces $190 Price Target

ARAY

Accuray Says Shandong Cancer Hospital And Institute Achieved Completion Of Treatment For 100 Patients Using The Tomo C Radiation Treatment Delivery System

Shares of Rivian Automotive Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>) and Lucid Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LCID#NASDAQ">LCID</a>) have declined sharply following President Donald Trump&#8217;s announcement of significant electric vehicle <a href="https://www.benzinga.com/trading-ideas/25/01/43116755/trumps-plan-to-end-7500-ev-tax-credits-could-be-devastating-for-telsa-rivals-poll-says-could-be-bullish-for-elon-musks-company">policy changes</a>. Technical analysis of these companies reflects a bleak picture for the stocks in the near term.
What Happened: According to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>, shares of Rivian fell by 10.93% and Lucid Group slid 12.70% over the last two trading sessions after Trump signed executive orders related to EV policies on his first day in office.
<figure class="wp-block-image size-large"><a href="https://pro.benzinga.com/dashboard"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23044559/RIVN-LICD-TWO-DAY-1024x576.png" alt="" class="wp-image-746424" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23044559/RIVN-LICD-TWO-DAY-1024x576.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23044559/RIVN-LICD-TWO-DAY-300x169.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23044559/RIVN-LICD-TWO-DAY-768x432.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23044559/RIVN-LICD-TWO-DAY-1536x864.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23044559/RIVN-LICD-TWO-DAY.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
The stocks of these EV makers have been under pressure over the speculation of Trump&#8217;s reversal of the tax credit worth $7,500.
According to the technical analysis of daily moving averages from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>, Rivian&#8217;s stock is under short-term pressure with longer-term support. Whereas, Lucid&#8217;s stock is undergoing a period of consolidation. 
<h4 class="wp-block-heading">Rivian Automotive</h4>
RIVN's shares closed at $12.69 apiece on Wednesday and it was below its eight-day simple moving average of $13.66 and its 20-day average of $14 apiece. It was also below its 50-day simple moving average of $12.82.
The stock was above its 200-day simple moving average of $12.28, suggesting support at this level in the longer term.
On the other hand, the relative strength index of 43.52 suggested that the stock is in a neutral zone.
<figure class="wp-block-image size-large"><a href="https://pro.benzinga.com/dashboard"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23035530/RIVN-Tech-chart-1024x576.png" alt="" class="wp-image-746364" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23035530/RIVN-Tech-chart-1024x576.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23035530/RIVN-Tech-chart-300x169.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23035530/RIVN-Tech-chart-768x432.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23035530/RIVN-Tech-chart-1536x864.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23035530/RIVN-Tech-chart.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
<h4 class="wp-block-heading">Lucid Group</h4>
LCID's shares closed at $2.67 apiece on Wednesday and it was below its eight-day simple moving average of $2.96 and its 20-day average of $3.08 apiece. The 200-day simple moving average was also above the share price at $2.93, signaling a bearish trend.
However, the stock was above its 50-day simple moving average of $2.59 acting as a support. Thus, suggesting a phase of consolidation.
On the other hand, the relative strength index of 41.69 indicates that the stock is in a neutral zone.
<figure class="wp-block-image size-large"><a href="https://pro.benzinga.com/dashboard"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23035549/LICD-Tech-Chart-1024x576.png" alt="" class="wp-image-746365" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23035549/LICD-Tech-Chart-1024x576.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23035549/LICD-Tech-Chart-300x169.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23035549/LICD-Tech-Chart-768x432.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23035549/LICD-Tech-Chart-1536x864.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23035549/LICD-Tech-Chart.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
See Also: <a href="https://www.benzinga.com/trading-ideas/25/01/43116755/trumps-plan-to-end-7500-ev-tax-credits-could-be-devastating-for-telsa-rivals-poll-says-could-be-bullish-for-elon-musks-company">Trump&#8217;s Plan To End $7,500 EV Tax Credits Could Be &#8216;Devastating&#8217; For Telsa Rivals, Poll Says Could Be Bullish For Elon Musk&#8217;s Company</a>
Why It Matters: After his swearing-in ceremony, Trump&#8217;s <a href="https://www.benzinga.com/trading-ideas/25/01/43116755/trumps-plan-to-end-7500-ev-tax-credits-could-be-devastating-for-telsa-rivals-poll-says-could-be-bullish-for-elon-musks-company">executive order</a> canceled the target set by Joe Biden in 2021, mandating 50% of EV sales in the U.S. by 2030.
President Trump also halted unspent funds from a $5 billion EV charging infrastructure program. The administration will also reassess emissions rules requiring automakers to sell 30% to 56% electric vehicles by 2032. Additionally, Trump plans to challenge California&#8217;s zero-emission vehicle mandate, also adopted by 11 other states.
Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) CEO Elon Musk, a major Trump supporter and the world&#8217;s richest person, in an X post dated July 16, 2024, said, &#8220;Take away the subsidies. It will only help Tesla.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Take away the subsidies. It will only help Tesla. Also, remove subsidies from all industries!
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1813112958157005259?ref_src=twsrc%5Etfw">July 16, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Following this, during a post-earnings call, when Tesla reported its lowest profit margin in over five years. Musk said, &#8220;It would be devastating for our competitors and hurt Tesla slightly, but long-term, it would probably actually help Tesla.&#8221;
For Rivian, known for electric trucks, SUVs, and delivery vans, the potential repeal of tax credits and reduced EV infrastructure funding could hurt demand for its premium vehicles. Lucid, another emerging <a href="https://www.benzinga.com/trading-ideas/movers/25/01/43113872/rivian-lucid-shares-are-falling-today-whats-going-on">EV brand</a>, faces similar challenges with reduced government incentives and infrastructure support, both key to its growth.
In premarket on Thursday, RIVN was down 0.39% and LCID fell by 1.50%.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/management/25/01/43073354/warren-buffett-openly-called-bitcoin-a-rat-poison-in-2018-7-years-later-he-is-invested-in-this-crypto-linked-stock-which-soared-27-in-2024">Warren Buffett Openly Called Bitcoin A &#8216;Rat Poison&#8217; In 2018. 7 Years Later, He Is Invested In This Crypto-Linked Stock Which Soared 27% In 2024 </a></li>
</ul>
Photo courtesy: Rivian

Market Summary

Technicals

Trading Ideas

LCID

RIVN

TSLA

Tesla Rivals Rivian, Lucid Fall Sharply After Donald Trump Revokes Biden's EV Targets, Freezes Infra Funding: Here's What Technical Analysis Says

Northern Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTRS#NASDAQ">NTRS</a>) reported quarterly earnings of $2.26 per share which beat the analyst consensus estimate of $1.99 by 13.57 percent. The company reported quarterly sales of $1.960 billion which beat the analyst consensus estimate of $1.935 billion by 1.31 percent. This is a 26.86 percent increase over sales of $1.545 billion the same period last year.

Earnings Beats

NTRS

Northern Trust Q4 2024 GAAP EPS $2.26 Beats $1.99 Estimate, Sales $1.960B Beat $1.935B Estimate

The World Trade Organization&#8217;s (WTO) chief issued a warning on Thursday about the potentially disastrous impact of trade wars on global economic growth.
What Happened: Ngozi Okonjo-Iweala, the WTO&#8217;s Director-General, voiced her concerns during a debate&nbsp;at the World Economic Forum&nbsp;in Davos, Reuters reported. The conversation centered around the <a href="https://www.benzinga.com/government/regulations/25/01/43083803/market-bets-on-trumps-tariff-announcement-plummet-dollar-falls-whats-going-on">tariff threats posed</a> by U.S. President Donald Trump.
Okonjo-Iweala warned that if a &#8220;tit-for-tat retaliation&#8221; trade war breaks out, with tariffs varying between 25% to 60%, the world might experience a situation akin to the 1930s. This could lead to double-digit global GDP losses, a scenario she termed as &#8220;catastrophic.&#8221;
See Also:&nbsp;<a href="https://www.benzinga.com/news/25/01/43152917/elon-musk-led-doge-targets-us-penny-over-179m-annual-production-cost" target="_blank" rel="noreferrer noopener">Elon Musk's DOGE Takes Aim At The US Penny Citing Soaring Production Costs</a>
&#8220;Everyone will pay,&#8221; cautioned the WTO chief, underlining the universal repercussions of such a trade conflict.
Why It Matters: These remarks come in the wake of Trump&#8217;s announcement of a <a href="https://www.benzinga.com/etfs/emerging-market-etfs/25/01/43130930/trump-looking-at-10-tariff-on-china-starting-feb-1">potential 10% tariff on Chinese goods,</a> which could be implemented as early as Feb. 1. This move has sparked concerns about a renewed trade conflict between the U.S. and China.
US-listed Chinese stocks initially surged on Tuesday, buoyed by President Trump&#8217;s inauguration speech, which surprisingly didn&#8217;t target China or impose immediate tariffs. However, the stocks — such as Baidu Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIDU#NASDAQ">BIDU</a>), Alibaba (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>), Li Auto Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LI#NASDAQ">LI</a>), and Xpeng Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPEV#NYSE">XPEV</a>) — were trading lower in Wednesday premarket after the president&#8217;s subsequent comments.
Despite the potential economic impact, some industry leaders, such as&nbsp;Jamie Dimon, <a href="https://www.benzinga.com/news/25/01/43150451/jamie-dimo-supports-trumps-tariffs-if-its-a-little-inflationary-but-its-good-for-national-security-so-be-it">have expressed support for Trump&#8217;s</a> proposed tariffs, citing national security benefits. &nbsp;"If it's a little inflationary, but it's&nbsp;good for national security, so&nbsp;be it. I mean, get&nbsp;over it," Dimon said.
Canada, a key player in U.S. trade, has also&nbsp;<a href="https://www.benzinga.com/news/25/01/42938083/justin-trudeau-says-canada-is-ready-to-respond-with-tariffs-as-necessary-amid-potential-trump-trade-war">indicated its readiness</a>&nbsp;to respond with tariffs if the U.S. initiates a trade conflict. &#8220;As we did last time, we are ready to respond with tariffs as necessary,&#8221; the outgoing Canadian prime minister said. In 2018, Canada swiftly responded to the Trump administration&#8217;s tariffs on steel and aluminum by imposing its own tariffs on various U.S. goods. These targeted goods included household appliances and whiskey, among others.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/43152627/microsoft-ceo-satya-nadella-stands-firm-after-elon-musk-questions-stargates-100-billion-funding-potential-all-i-know-is-im-good-for-my-80-billion" target="_blank" rel="noreferrer noopener">Satya Nadella Stands Firm After Elon Musk Questions Stargate's $100 Billion Funding Potential: ‘All I Know Is, I'm Good For My $80 Billion'</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Image via Shutterstock

WTO Chief Says 'Everyone Will Pay' If 'Tit-For-Tat' Trade War Breaks Out Amid Trump's Tariff Threat, Leading To Double-Digit Global GDP Losses

Top Wall Street analysts initiated coverage on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>BMO Capital analyst Jack Matten initiated coverage on Prudential Financial, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRU#NYSE">PRU</a>) with an Underperform rating and announced a price target of $101. Prudential Financial shares closed at $117.35 on Wednesday. <a href="https://www.benzinga.com/quote/PRU/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>HC Wainwright &amp; Co. analyst Kevin Dede initiated coverage on Exodus Movement, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EXOD#NYSE">EXOD</a>) with a Buy rating and announced a price target of $50. Exodus Movement shares closed at $41.00 on Wednesday. <a href="https://www.benzinga.com/quote/EXOD/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Piper Sandler analyst Yasmeen Rahimi initiated coverage on Bright Minds Biosciences Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRUG#NASDAQ">DRUG</a>) with an Overweight rating and announced a price target of $93. Bright Minds Biosciences shares closed at $33.35 on Wednesday. <a href="https://www.benzinga.com/quote/DRUG/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Raymond James analyst Daniel Magder initiated coverage on Electrovaya Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELVA#NASDAQ">ELVA</a>) with a Strong Buy rating and announced a price target of $4.5. Electrovaya shares closed at $2.52 on Wednesday. <a href="https://www.benzinga.com/quote/ELVA/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Roth MKM analyst Chip Moore initiated coverage on Innventure, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INV#NASDAQ">INV</a>) with a Buy rating and announced a price target of $16. Innventure shares closed at $12.42 on Wednesday. <a href="https://www.benzinga.com/quote/INV/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying PRU stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="624" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23073115/image-170-1024x624.png" alt="" class="wp-image-746649" style="width:535px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23073115/image-170-1024x624.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23073115/image-170-300x183.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23073115/image-170-768x468.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23073115/image-170.png 1083w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/01/43126364/jim-cramer-this-tech-stock-is-a-buy-amd-is-a-great-company">Jim Cramer: AMD Is A &#8216;Great&#8217; Company, Hold Onto Dow Inc.</a></li>
</ul>

Initiation

Pre-Market Outlook

DRUG

ELVA

EXOD

This Prudential Financial Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday

Keybanc analyst Ashley Owens upgrades Revolve Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RVLV#NYSE">RVLV</a>) from Sector Weight to Overweight and announces $37 price target.

RVLV

Keybanc Upgrades Revolve Gr to Overweight, Announces $37 Price Target

The higher dose regimen of nusinersen comprises a more rapid loading regimen, two 50 mg doses 14 days apart, and higher maintenance regimen, 28 mg, every 4 months, compared to the approved nusinersen regimen (SPINRAZA).&nbsp;

Biotech

Large Cap

BIIB

The FDA Has Accepted Biogen's Supplemental New Drug Application And The European Medicines Agency Has Validated The Application For A Higher Dose Regimen Of Nusinersen For Spinal Muscular Atrophy

Contracts

RCAT

Red Cat Secures New Orders For Its Edge 130 Drone From The Army National Guard And Another U.S. Government Agency, Totaling $518K

D. Boral Capital analyst Jason Kolbert maintains UroGen Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/URGN#NASDAQ">URGN</a>) with a Buy and maintains $25 price target.

URGN

D. Boral Capital Maintains Buy on UroGen Pharma, Maintains $25 Price Target

VS-7375 is on track for U.S. IND filing in Q1 2025 with plans for a Phase 1/2a study in mid-2025. Cash position following recent debt and equity financing provides expected runway beyond potential FDA approval and helps to advance early-stage pipeline.
 &nbsp;
 &nbsp;

VSTM

Verastem Oncology Unveils 2025 Priorities And Upcoming Catalysts For Its Novel Clinical Pipeline;

<ul>
<li>Demonstrated bioavailability of IHL-42X, Incannex's proprietary combination formulation, confirming delivery of both dronabinol and acetazolamide</li>
<li>Achieved similar PK and equivalent total drug exposure levels of IHL-42X and the reference listed drugs (RLD) for dronabinol and acetazolamide, building a scientific bridge to established safety and toxicology data with the potential to support a future FDA 505(b)(2) new drug application (NDA)</li>
<li>Pharmacokinetic results for IHL-42X will inform analysis of anticipated Phase 2/3 data assessing IHL-42X in patients with obstructive sleep apnea</li>
<li>Continued excellent safety and tolerability findings, with no serious adverse events reported</li>
</ul>

IXHL

Incannex Healthcare Announced Topline Results From A Completed Pharmacokinetics And Safety Study Of IHL-42X For Obstructive Sleep Apnea

Baird analyst Luke Junk maintains TE Connectivity (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TEL#NYSE">TEL</a>) with a Outperform and raises the price target from $162 to $168.

Baird Maintains Outperform on TE Connectivity, Raises Price Target to $168

Rosenblatt analyst Steven Frankel maintains Dolby Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLB#NYSE">DLB</a>) with a Buy and maintains $100 price target.

Rosenblatt Maintains Buy on Dolby Laboratories, Maintains $100 Price Target

Sports company&nbsp;Puma SE (OTC:<a class="ticker" href="https://www.benzinga.com/stock/PMMAF#OTC">PMMAF</a>) reported fourth-quarter sales growth of 9.8% on a currency-adjusted basis, <a target="_blank" href="https://about.puma.com/en/newsroom/corporate-news/2025/22-01-2025-puma-announces-preliminary-results-fourth-quarter-and-full" rel="noreferrer noopener">totaling 2.289 billion euros</a> (~$2.38 billion). The growth was 15.5% reported on a reported basis.
Overall growth in EMEA was 14.3%, Europe (+10.3%), Greater China (+7.4%), Other APAC (+19.0%), and North America (+2.6%).
However, sales growth in LATAM remained relatively softer at +7.0%. PUMA&#8217;s Footwear and Apparel businesses grew by 9.2% and 8.8%, respectively, while Accessories saw a 14.5% increase.
PUMA reported an EBIT of 109 million euros, up from 94 million euros in the same quarter of 2023, with net income surging to 24 million euros, compared to 1 million euros last year, although both figures still fell short of expectations.
Full-year sales grew by 4.4% (currency-adjusted) to 8.817 billion euros, meeting its expectations.
&#8220;While we achieved solid sales growth in 2024 and made meaningful progress on our strategic initiatives, we are not satisfied with our profitability, &#8220;said CEO Arne Freundt.
Related Read: <a target="_blank" href="https://www.benzinga.com/25/01/43121964/adidas-sees-solid-gains-in-q4-looks-to-expand-market-share" rel="noreferrer noopener">Adidas Sees Solid Gains In Q4, Looks To Expand Market Share</a>
&#8220;Combined with decisive actions already taken, we will implement further cost control measures in 2025.&#8221;
The company reported an operating result (EBIT) of 622 million euros for the full year, remaining flat year-on-year. However, net income came in lower at 282 million euros, down from 305 million euros in 2023, primarily due to increased net interest expenses and higher non-controlling interests.
In response to its financial performance, PUMA unveiled a new cost-efficiency program, &#8220;nextlevel,&#8221; which aims to achieve an EBIT margin of 8.5% by 2027.
The program is expected to improve PUMA&#8217;s underlying operating results starting in 2025, with the long-term goal of reaching a 10% EBIT margin.
This program is part of PUMA&#8217;s strategic efforts to streamline operations and improve profitability over the next few years.
Price Action: PMMAF shares closed lower by 3.43% at $40.27 on Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/43124975/why-gillette-parent-procter-gambles-stock-is-rising-today" target="_blank" rel="noreferrer noopener">Gillette Parent Procter &amp; Gamble Q2 Earnings: Navigates Commodity And Forex Challenges, Maintains Core FY25 Outlook</a></li>
</ul>
Photo via Shutterstock..

Comments

Li Auto

Li Auto (LI) Forecast

Li Auto (NASDAQ:LI) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga